By: IPP Bureau
Last updated : August 12, 2024 8:11 am
Revenue up 16.3% to Rs 5,600 crore versus Rs 4,814 crore
Pharma major Lupin Limited reported its financial performance for the quarter ending June 30, 2024. The company posted a net profit of Rs 805.54 crore in the quarter-ended June in comparison with Rs 453.33 crore in the year-ago period.
Lupin Q1 FY25 Highlights (Consolidated, YoY)
*Revenue up 16.3% to Rs 5,600 crore versus Rs 4,814 crore
*Ebitda up 50.1% to Rs 1,286 crore versus Rs 856 crore
* Margin at 23% versus 17.8%
* Net profit up 78% to Rs 805.54 crore versus Rs 453.33 crore
Commenting on the results, Nilesh Gupta, Managing Director, Lupin Limited said, “We have had a strong quarter on the back of the momentum we built through FY24, with performance driven by new products, key geographies, and improvement in our operating margin and profitability. We are on track for strong, sustainable growth and margin improvement backed by growth in sales, commercial and operating efficiencies, and a strong compliance story.”